Journal of Blood Medicine
Volume 9, 2018 - Issue
Open access
141
Views
17
CrossRef citations to date
0
Altmetric
Review
Inotuzumab ozogamicin in the treatment of relapsed/refractory acute B cell lymphoblastic leukemia
Natalie UySection of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA
, Michelle NadeauSection of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA
, Maximilian StahlSection of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA
& Amer M ZeidanSection of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USACorrespondence[email protected]
Pages 67-74
|
Published online: 13 Apr 2018
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.